SAN JOSE, Calif., Oct. 22 /PRNewswire-FirstCall/ -- The start of the patent lawsuit by VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS) against three endovenous laser competitors, Diomed, AngioDynamics and Vascular Solutions, has been delayed from a previously scheduled start date of October 29. The delay is due to a busy court calendar. A court conference is scheduled for October 26 to identify potential new trial start dates. At the conference, the parties will seek to have the trial start during the first quarter of 2008.
In addition, the judge today issued a ruling denying defendants' summary judgment motion that asked to declare two of VNUS' patents invalid. Accordingly, the case will proceed to trial on all three of the patents that VNUS seeks to enforce.
ABOUT VNUS MEDICAL TECHNOLOGIES, INC.
VNUS Medical Technologies (Nasdaq: VNUS) is a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that causes the varicose veins afflicting 25 million Americans. The pioneering company in the field, VNUS now offers the ClosureFAST(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. For more information, please visit http://www.vnus.com.
In addition to statements of historical facts or statements of current conditions, VNUS has made forward-looking statements in this press release regarding patent litigation. The reader is cautioned not to unduly rely on these forward-looking statements. VNUS expressly disclaims any intent or obligation to update these forward-looking statements except as required by law.
|SOURCE VNUS Medical Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved